Growth Metrics

Biodesix (BDSX) Change in Cash (2019 - 2026)

Biodesix filings provide 8 years of Change in Cash readings, the most recent being $6.6 million for Q1 2026.

  • On a quarterly basis, Change in Cash rose 176.2% to $6.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $8.0 million, a 30.4% increase, with the full-year FY2025 number at -$7.3 million, down 18507.69% from a year prior.
  • Change in Cash hit $6.6 million in Q1 2026 for Biodesix, up from $2.4 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $30.7 million in Q2 2024 to a low of -$17.8 million in Q1 2023.
  • Median Change in Cash over the past 5 years was -$4.1 million (2025), compared with a mean of -$419882.4.
  • Biggest five-year swings in Change in Cash: soared 1092.06% in 2022 and later plummeted 544.8% in 2024.
  • Biodesix's Change in Cash stood at $27.9 million in 2022, then tumbled by 76.91% to $6.4 million in 2023, then crashed by 180.09% to -$5.2 million in 2024, then skyrocketed by 146.17% to $2.4 million in 2025, then skyrocketed by 176.33% to $6.6 million in 2026.
  • The last three reported values for Change in Cash were $6.6 million (Q1 2026), $2.4 million (Q4 2025), and -$4.1 million (Q3 2025) per Business Quant data.